CRAFTSMAN®, Ace Hardware Foundation and Joe Gibbs Racing Team Up for Annual Racing for a Miracle Program
Ten children from the hospital will be honorary junior crew members for NASCAR driver Christopher Bell
Junior crew members' art will be featured on Bell's No. 20 car in the July 6 race
CRAFTSMAN will donate $100,000 to the Ace Hardware Foundation in support of CMN Hospitals
Ace Hardware is celebrating CRAFTSMAN's continued support by offering customers 20% off** select CRAFTSMAN V20* Power Tools, Outdoor Power Equipment and Accessories
CHICAGO, July 2, 2025 /PRNewswire/ — CRAFTSMAN®, a Stanley Black & Decker brand (NYSE: SWK), is proudly teaming up once again with the Ace Hardware Foundation and NASCAR driver Christopher Bell of Joe Gibbs Racing for the 19th Annual Racing for a Miracle program, which supports Children's Miracle Network Hospitals (CMN Hospitals).
This year, CRAFTSMAN is donating $100,000 to the Ace Hardware Foundation for CMN Hospitals. Since 2006, Stanley Black & Decker and its brands have contributed more than $1.9 million to the Racing for a Miracle program. The program provides funding for vital treatments and healthcare services for children and their families at 170 CMN Hospitals across the U.S. and Canada.
'For nearly 20 years, we have seen firsthand the impact Racing for a Miracle, and our partnership with Ace Hardware Foundation and CMN Hospitals, has had for children and their families. We're always so inspired by their stories, and their strength and perseverance,' said Tony Merritt, Vice President of Sponsorships for Stanley Black & Decker. 'We're proud to be part of this legacy and happy to celebrate the incredible impact this program has made.'
The donation to the Ace Hardware Foundation will take place during a tailgate at Ace Hardware corporate headquarters. At the tailgate, CRAFTSMAN, Ace Hardware and Christopher Bell will unveil the design for 2025 CRAFTSMAN Racing for a Miracle car with the help of ten children from the Ann & Robert H. Lurie Children's Hospital in Chicago.
Ace Hardware Offers Special CRAFTSMAN® PromotionAdditionally, Ace Hardware is celebrating CRAFTSMAN's continued support of the Ace Hardware Foundation and the Racing for a Miracle program by offering customers 20% off** select CRAFTSMAN V20* Power Tools, Outdoor Power Equipment and Accessories. This offer is exclusive to Ace Hardware and is valid June 25th, 2025 through July 31, 2025 in-store and online.
Visit www.craftsman.com or follow CRAFTSMAN® on Facebook and Instagram for updates on this year's Racing for a Miracle program.
*Maximum initial battery voltage (measured without a workload) is 20 volts. Nominal voltage is 18 volts.**See store or http://www.acehardware.com/racing-for-a-miracle for details and eligible products. Offer valid only on qualifying CRAFTSMAN products purchased 6/25/2025 through 7/31/2025, while supplies last. Offer valid at participating Ace Hardware stores, on acehardware.com, and the Ace mobile app. May not be combined with any other discount or offer and does not apply to prior purchases. Discount does not apply to tax, shipping and handling, or assembly. If merchandise is returned, customer will receive discounted price paid. Other restrictions may apply. Void where prohibited.
About CRAFTSMANCRAFTSMAN is the most trusted and recommended brand in Tools and Outdoor by DIYers.* With solutions for the home, yard and garage, CRAFTSMAN is committed to empowering DIYers at every stage of their journey. Crafted with the same innovation and expertise homeowners have come to expect and love, CRAFTSMAN is here to help DIYers BUILD ON™. For more information, visit www.craftsman.com or follow CRAFTSMAN on Facebook and Instagram.
About Stanley Black & DeckerFounded in 1843 and headquartered in the USA, Stanley Black & Decker (NYSE: SWK) is a worldwide leader in Tools and Outdoor, operating manufacturing facilities globally. The Company's approximately 48,000 employees produce innovative end-user inspired power tools, hand tools, storage, digital jobsite solutions, outdoor and lifestyle products, and engineered fasteners to support the world's builders, tradespeople and DIYers. The Company's world class portfolio of trusted brands includes DEWALT®, CRAFTSMAN®, STANLEY®, BLACK+DECKER®, and Cub Cadet®. To learn more visit: www.stanleyblackanddecker.com or follow Stanley Black & Decker on Facebook, Instagram, LinkedIn and X.
About Children's Miracle Network Hospitals Children's Miracle Network Hospitals was founded more than 40 years ago with the vision to Change Kids' Health, Change the Future. We've raised over $9 billion for 170 children's hospitals by empowering and engaging with local communities and businesses – and we're not done yet. All donations benefit local member hospitals to fund what's needed most, like critical life-saving treatments and healthcare services, innovative research, vital pediatric medical equipment, child life services that put kids' and families' minds at ease during difficult hospital stays, and financial assistance for families who could not otherwise afford these health services. Together, we can change kids' health. Together, we can change the future. To learn about Children's Miracle Network Hospitals and your local member children's hospital, visit cmnhospitals.org.
About Ace Hardware Ace Hardware is the largest retailer-owned hardware cooperative in the world with over 5,800 locally owned and operated hardware stores in approximately 60 countries. Headquartered in Oak Brook, Ill., Ace and its subsidiaries operate an expansive network of distribution centers in the U.S. and have distribution capabilities in Ningbo, China; Cuautitlán Izcalli, Mexico. Ace also owns Ace Hardware Home Services, a collection of local service companies with experienced professionals dedicated to helping homeowners complete home maintenance tasks. Since 1924, Ace has become a part of local communities around the world and known as the place with the Helpful Hardware Folks. For more information, visit acehardware.com or newsroom.acehardware.com.
*Rated among 25 leading competitive brands, based on online national survey of 261 DIY tool and residential outdoor power equipment owners ages 18+, conducted in 10/2024.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
3 hours ago
- Malaysian Reserve
American Express Leadership Academy Returns to London with Dior Creative Director Jonathan Anderson
The four-day program, created in partnership with Common Purpose, will feature Anderson and a dynamic lineup of programming for nonprofit leaders from 24 countries LONDON, July 3, 2025 /PRNewswire/ — American Express today announced that Jonathan Anderson, acclaimed creative director of Dior, former creative director of Loewe, and founder of JW Anderson, will join the 2025 American Express Leadership Academy in London to address nonprofit leaders on how to lead through innovation and drive impact. Anderson's appearance marks a major milestone for the Academy, introducing one of the most influential voices in global design and creative leadership to nonprofit leaders participating in the London program. Anderson will be in conversation with Alexander Fury, fashion features director at large for Another Magazine and menswear critic at Financial Times. Hosted in partnership with Common Purpose, the American Express Leadership Academy's London program will welcome 78 nonprofit leaders from two dozen countries in Europe, the Middle East, and Africa in early July. Founded in 2007, the Academy is designed to build the personal, business, and communication skills of leaders through multi-day in-person and virtual programming. Since its launch, American Express has invested approximately $100 million in the Academy and has helped more than 165,000 leaders around the world reach their potential. 'For 18 years, the American Express Leadership Academy has been bringing together nonprofit leaders to build their leadership skills and strategic mindset to drive meaningful change,' said Jennifer Skyler, Chief Corporate Affairs Officer at American Express. 'As a visionary in the fashion world, Jonathan Anderson will share his philosophy on leading global creative brands with creativity, purpose, and resilience, as we continue to gather bold thinkers across sectors to learn from one another and accelerate their global impact.' This year's London program will feature a robust schedule of learning opportunities, including storytelling workshops, immersive visits with other nonprofits, and group projects on topics like building an innovative mindset. As the final stop for this year, the American Express Leadership Academy will head to New York in November. To apply for the 2025 Americas cohort or register for future cohorts around the world, click here. ABOUT AMERICAN EXPRESS American Express (NYSE: AXP) is a global, premium payments and lifestyle brand powered by technology. Our colleagues around the world back our customers with differentiated products, services and experiences that enrich lives and build business success. Founded in 1850 and headquartered in New York, American Express' brand is built on trust, security, and service, and a rich history of delivering innovation and Membership value for our customers. With a hundred million merchant locations on our global network in over 200 countries and territories, we seek to provide the world's best customer experience every day to a broad range of consumers, small and medium-sized businesses, and large corporations. For more information about American Express, visit and MEDIA CONTACT: Jessica Logo – View original content:
The Sun
8 hours ago
- The Sun
Cushman & Wakefield and Corenet Global Release New Survey Results On 'What Occupiers Want'
HONG KONG SAR - Media OutReach Newswire - 2 July 2025 - Cushman & Wakefield (NYSE: CWK), in partnership with CoreNet Global, the global professional association for corporate real estate, has released new survey results revealing how corporate real estate (CRE) priorities are evolving in response to cost pressures, shifting organizational models, a stabilizing office footprint, and the growing demand for workplace flexibility and service. Findings from the What Occupiers Want 2025 survey—reflecting the views of CRE decision-makers across the Americas (52%), EMEA (34%) and APAC (14%)—highlight an industry at a strategic crossroads, as companies balance traditional cost control measures with new imperatives around talent, culture, and portfolio agility. The views represent approximately 8.1 million employees globally and approximately 340M square feet of floor area. 'The survey shows that while cost discipline remains essential, organizations are increasingly recognizing that real estate decisions directly impact employee experience, engagement, and overall business performance,' said Despina Katsikakis, Global Lead, Total Workplace Consulting at Cushman & Wakefield. 'This marks a critical opportunity for CRE leaders to shape strategies that deliver both financial and workforce value.' Cost Still Reigns, but Uncertainty Dominates Decision-Making Cost control remains the top driver of corporate real estate decisions globally, as CRE leaders face continued pressure to reduce or optimize spending. Financial KPIs—particularly cost, efficiency, and space utilization—still dominate strategy. However, uncertainty looms large. Political instability, changing workplace behaviors, and unclear ROI metrics have left many organizations hesitant to act boldly. Compounding this, environmental, social, and governance (ESG) priorities—once on the rise—have slipped back to pre-2021 levels in global importance, though they remain a top concern in EMEA and APAC regions. CRE Organizational Models Are Evolving—And Metrics Must Keep Pace One of the report's most striking findings: nearly one-third (29%) of companies that recently changed their CRE reporting structure now have real estate teams reporting to Human Resources. 'This shift highlights a growing understanding that corporate real estate is about people, culture, and experience—not just space and cost,' said Katsikakis. 'But to make this evolution meaningful, organizations need new performance metrics that link workplace investments to employee experience, engagement, and productivity—not just financial outcomes.' Despite these organizational changes, most companies continue to rely heavily on traditional financial measures. The report calls for a balanced scorecard approach that bridges the gap between cost control and workforce impact. Downsizing Has Peaked as Occupiers Stabilize Portfolios After several years of footprint reduction, the era of mass downsizing appears to be over. Only 32% of companies plan further space cuts, while 1 in 8 occupiers plan to expand their footprint. Meanwhile, average office lease sizes have grown by 13% since 2023. Office utilization rates are stabilizing as well, with global occupancy levels settling between 51% and 60%—still below pre-pandemic norms but rising steadily as more firms implement structured return-to-office policies. Landlords Must Step Up as the Office Becomes a Service Tenants are demanding more from their landlords—85% of occupiers now expect landlords to provide enhanced amenities, services, and workplace experiences, and nearly half (46%) are willing to pay a premium for these upgrades. Top-tier office space commands a nearly double-digit rental premium as a result. Yet there remains a gap between expectation and delivery: only 60% of employees believe their current workplace fully supports collaboration, relationships, and culture-building—the very elements that draw people back to the office. Flexible Location Strategies Are the New Talent Imperative Flexible hiring practices are now standard, with 61% of companies adapting their real estate strategies to access diverse talent pools across multiple geographies. Regional trends show varied approaches: • In the Americas, hybrid and country-level hiring dominate. • EMEA firms favor selective global hiring where presence already exists. • APAC leads in expanding remote hiring options. Technology talent remains in high demand, particularly in APAC, where growth outpaces that of the Americas and EMEA. The 2025 What Occupiers Want survey reveals a CRE industry in transition: while cost pressures remain paramount, leading organizations are redefining value beyond financial savings. 'To drive meaningful impact, CRE leaders must champion new, integrated performance frameworks that reflect the true business value of the workplace,' said Katsikakis. 'Real estate decisions are no longer just about the bottom line—they're about workforce performance, culture, and competitive advantage.' Spotlight: Chinese Mainland On the Chinese mainland, occupier strategies are aligning with the broader Asia Pacific trends – but with distinct local drivers. Companies continue to prioritize cost optimization and footprint efficiency, but there is a growing shift toward premium office space in core business districts, especially among financial, professional services, and high-tech sectors. Return-to-office policies are further along compared to other global markets, with hybrid models giving way to more structured, on-site work requirements. Occupiers are seeking environments that enhance collaboration, innovation, and talent retention – particularly in Shanghai, Beijing, and Shenzhen, where talent competition remains intense. 'Occupiers in China are increasingly focused on quality—not just in location and amenities, but in how the workplace supports business strategy and employee wellbeing,' said Jonathan Wei, Head of Project and Occupier Services, China at Cushman & Wakefield. 'Landlords who can deliver integrated, experience-driven environments with flexible, tech-enabled solutions are strongly positioned to attract and retain long-term tenants.'
Malaysian Reserve
14 hours ago
- Malaysian Reserve
Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001
Highlights: Neurizon® Therapeutics and Elanco Animal Health enter into an exclusive global licensing agreement Provides worldwide rights for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing data and outlines key terms for a future supply agreement for GMP-compliant Monepantel Provides a clear pathway for accelerated global commercialisation of NUZ-001[1] and significantly de-risks future global regulatory approval processes The license agreement represents the first step in formalising Neurizon's relationship with Elanco, with the next step focused on finalising a supply agreement expected H2 CY 2025 MELBOURNE, Australia, July 2, 2025 /PRNewswire/ — Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ('Neurizon' or 'the Company'), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce it has executed an exclusive global license agreement with Elanco Animal Health Incorporated (Elanco; NYSE: ELAN) and affiliates for Monepantel, the active pharmaceutical ingredient in NUZ-001, Neurizon's lead investigational therapy in development for Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases in humans. This license agreement represents a critical inflection point for Neurizon, further strengthening the Company's strategic outlook for the development, manufacturing and potential future commercialisation of NUZ-001. It also significantly supports the Company's regulatory foundations, providing ongoing access to critical animal safety data and manufacturing data, key pillars required to support future clinical trials, potential regulatory approvals and global market entry. Dr. Michael Thurn, Managing Director and Chief Executive Officer, commented: 'This license agreement with Elanco marks a watershed moment in Neurizon's journey to become a leader in the accelerated development of treatments for neurodegenerative diseases. This strategic milestone provides exclusive access to a comprehensive package of non-clinical studies and manufacturing data, dramatically reducing near-term development costs and accelerating development timelines. All of this is in exchange for a nominal up-front payment, small back-ended regulatory approval and commercial sale milestones and single-digit royalty payments on future global net sales. Neurizon is now well-positioned to accelerate the path to market and advance new treatment options for people affected by devastating neurodegenerative diseases.' Mr. Sergio Duchini, Non-Executive Chairman, commented: 'On behalf of the Board, I am pleased to endorse this landmark agreement with Elanco, which represents a strategically significant step forward for Neurizon. This agreement not only strengthens our clinical and regulatory position but also reflects our strong commitment to accelerating the development of meaningful therapies for people living with neurodegenerative diseases. We are also very happy to be making this important step in formalising our relationship with Elanco and look forward to building on this foundation as we progress towards finalising a supply agreement later this year.' Key Terms of the Licensing Agreement: Exclusive Global Rights: Neurizon is granted exclusive global rights to Elanco's data package and related intellectual property for monepantel to develop and commercialise NUZ-001 and its related compounds for the treatment, palliation, prevention, or cure of neurodegenerative diseases in humans. Upfront Payment: A nominal upfront licensing fee is payable to Elanco upon execution of the agreement[2]. Milestone Payments: Total Development milestone payments for the initial and subsequent licensed products, indications, or presentations of US$9.75 million and US$5.2 million, respectively. Elanco will also be eligible for milestone payments of up to US $65 million based on sales milestones[3]. Royalties: Elanco will receive tiered single-digit royalties on global net sales of licensed products. Supply: The agreement outlines certain key terms, including duration and price, for the conclusion of a Supply Agreement. Supply Agreement Neurizon and Elanco remain focused on finalising a supply agreement, with a follow-up announcement anticipated in H2 CY 2025. This next phase of the collaboration is expected to provide Neurizon with long-term, scalable source of GMP-compliant monepantel to support ongoing clinical development, regulatory submissions, and future global commercialisation of NUZ-001. -ENDS- This announcement has been authorized for release by the Board of Neurizon Therapeutics Limited. About Neurizon Therapeutics Limited Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients while exploring NUZ-001's potential for broader neurodegenerative applications. Through international collaborations and rigorous clinical programs, Neurizon is dedicated to creating new horizons for patients and families impacted by complex neural disorders. Neurizon® is a registered trademark of Neurizon Therapeutics Limited [1] NUZ-001 is Neurizon Therapeutics formulation of monepantel for use in neurodegeneration applications. [2] The amount is not material to Neurizon's current cash position [3] If triggered, the sales milestone payments will not fall due until six months after the first commercial sale. The remaining regulatory and commercial milestone payments will become due 30 days after the relevant milestone is met.
